{"transactions":[{"id":711020,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T23:37:10.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\").  One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date."}],"balance_after":21800,"source":{"system":"sec-edgar","filing":"0001820365-26-000009","document":"form4-07102026_110706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000182036526000009/form4-07102026_110706.xml","form_type":"4"}},{"id":745766,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:25:07.000Z","date":"2026-05-30","kind":"grant","planned":false,"acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments."}],"balance_after":1626,"derivative":{"exercise_price":21.9,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":1626},"source":{"system":"sec-edgar","filing":"0001820365-26-000006","document":"form4-06082026_080603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000182036526000006/form4-06082026_080603.xml","form_type":"4"}},{"id":1763390,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-10-06T17:28:22.000Z","date":"2023-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":19993,"price":0.44,"value":8796.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Securities beneficially owned are comprised of 285,341 shares of common stock owned which vest quarterly over a\nfour-year period from the date of grant."}],"balance_after":285341,"source":{"system":"sec-edgar","filing":"0001437749-23-027868","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000143774923027868/rdgdoc.xml","form_type":"4"}},{"id":1833567,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-07-06T09:53:11.000Z","date":"2023-07-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":19993,"price":0.914,"value":18273.602,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Securities beneficially owned are comprised of (1) 239,461 shares of common stock owned and (2) unvested restricted stock units aggregating 65,873 related to annual awards, which vest quarterly over a four-year period from date of grant."}],"balance_after":305334,"source":{"system":"sec-edgar","filing":"0001368148-23-000069","document":"wf-form4_168865156205949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814823000069/wf-form4_168865156205949.xml","form_type":"4"}},{"id":1924704,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-04-05T16:04:47.000Z","date":"2023-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":19993,"price":1,"value":19993.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Securities beneficially owned are comprised of (1) 193,581 shares of common stock owned and (2) unvested restricted stock units aggregating 131,746 related to annual awards, which vest quarterly over a four-year period from date of grant."}],"balance_after":325327,"source":{"system":"sec-edgar","filing":"0001368148-23-000031","document":"wf-form4_168072507291634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814823000031/wf-form4_168072507291634.xml","form_type":"4"}},{"id":2060046,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-01-06T18:05:19.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":23484,"price":0.85,"value":19961.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Securities beneficially owned are comprised of (1) 147,701 shares of common stock owned and (2) unvested restricted stock units aggregating 197,619 related to annual awards, which vest quarterly over a four-year period from the date of grant."}],"balance_after":345320,"source":{"system":"sec-edgar","filing":"0001368148-23-000007","document":"wf-form4_167304630532391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814823000007/wf-form4_167304630532391.xml","form_type":"4"}},{"id":2106653,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-11-22T15:53:56.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":100000,"price":0.5496,"value":54960.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at $0.54 and $0.55. The reporting person undertakes to provide to Athersys, Inc., any security holder of Athersys, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":368804,"source":{"system":"sec-edgar","filing":"0001368148-22-000157","document":"wf-form4_166915042016905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814822000157/wf-form4_166915042016905.xml","form_type":"4"}},{"id":2141099,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-06T12:56:33.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":263492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the exempt acquisition of 263,492 restricted stock units that in general will vest in substantially equal quarterly installments over one year from the date of grant of October 4, 2022, subject generally to the Reporting Person's continued employment with the Issuer or its subsidiaries."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 26, 2022, the Issuer effected a 1-for-25 reverse stock split of its Common Stock (the \"Reverse Stock Split\"), resulting in a decrease in the Reporting Person's ownership by 127,488 shares."}],"balance_after":268804,"source":{"system":"sec-edgar","filing":"0000899243-22-033112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000089924322033112/doc4.xml","form_type":"4"}},{"id":2326623,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-17T11:09:26.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":132800,"price":0.77,"value":102256.0,"ownership":{"direct":true},"balance_after":132800,"source":{"system":"sec-edgar","filing":"0001368148-22-000023","document":"wf-form4_164752975353681.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814822000023/wf-form4_164752975353681.xml","form_type":"4"}},{"id":2397368,"issuer":{"id":95922,"kind":"organization","name":"ATHERSYS, INC / NEW","symbol":"ATHX"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to purchase)","published_at":"2022-02-14T17:41:44.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":4000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the option vests on the one-year anniversary date of the grant and the remainder vests in equal monthly installments over the following three years."}],"balance_after":4000000,"derivative":{"exercise_price":0.86,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":4000000},"source":{"system":"sec-edgar","filing":"0001368148-22-000010","document":"wf-form4_164487844952952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368148/000136814822000010/wf-form4_164487844952952.xml","form_type":"4"}},{"id":2757752,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Employee stock option (right to buy)","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":3441,"derivative":{"exercise_price":15.23,"expiration_date":"2026-05-03","underlying":"Ordinary shares","underlying_shares":509},"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2757751,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Employee stock option (right to buy)","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":15467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":4333,"derivative":{"exercise_price":25.52,"expiration_date":"2025-09-22","underlying":"Ordinary shares","underlying_shares":15467},"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2757750,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Employee stock option (right to buy)","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":2305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.19,"expiration_date":"2027-02-21","underlying":"Ordinary shares","underlying_shares":2305},"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2757749,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary shares","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":509,"price":15.23,"value":7752.07,"ownership":{"direct":true},"balance_after":51181,"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2757748,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary shares","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":15467,"price":25.52,"value":394717.84,"ownership":{"direct":true},"balance_after":50672,"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2757747,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary shares","published_at":"2021-04-05T17:25:18.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":2305,"price":17.19,"value":39622.95,"ownership":{"direct":true},"balance_after":35205,"source":{"system":"sec-edgar","filing":"0001209191-21-025270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121025270/doc4.xml","form_type":"4"}},{"id":2766351,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-03-31T17:11:31.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":3517,"price":86.87,"value":305521.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.60 to $87.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":32900,"source":{"system":"sec-edgar","filing":"0001209191-21-023819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121023819/doc4.xml","form_type":"4"}},{"id":2766350,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-03-31T17:11:31.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":2986,"price":85.88,"value":256437.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.55 to $86.545 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36417,"source":{"system":"sec-edgar","filing":"0001209191-21-023819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121023819/doc4.xml","form_type":"4"}},{"id":2766349,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-03-31T17:11:31.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":4594,"price":84.97,"value":390352.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.53 to $85.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":39403,"source":{"system":"sec-edgar","filing":"0001209191-21-023819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121023819/doc4.xml","form_type":"4"}},{"id":2766348,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-03-31T17:11:31.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":1803,"price":83.58,"value":150694.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.23 to $84.095 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43997,"source":{"system":"sec-edgar","filing":"0001209191-21-023819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121023819/doc4.xml","form_type":"4"}},{"id":2839226,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units","published_at":"2021-02-23T18:18:24.000Z","date":"2021-02-21","kind":"exercise","acquired":false,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2021-02-21","expiration_date":"2021-02-21","underlying":"Ordinary Shares","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-21-013376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121013376/doc4.xml","form_type":"4"}},{"id":2839225,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:18:24.000Z","date":"2021-02-21","kind":"tax_withholding","acquired":false,"shares":576,"price":88.87,"value":51189.12,"ownership":{"direct":true},"balance_after":45800,"source":{"system":"sec-edgar","filing":"0001209191-21-013376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121013376/doc4.xml","form_type":"4"}},{"id":2839224,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:18:24.000Z","date":"2021-02-21","kind":"exercise","acquired":true,"shares":1300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":46376,"source":{"system":"sec-edgar","filing":"0001209191-21-013376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121013376/doc4.xml","form_type":"4"}},{"id":2899238,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-01-22T21:09:38.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":3220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2021-01-21","expiration_date":"2021-01-21","underlying":"Ordinary Shares","underlying_shares":3220},"source":{"system":"sec-edgar","filing":"0001209191-21-005003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121005003/doc4.xml","form_type":"4"}},{"id":2899237,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-01-22T21:09:38.000Z","date":"2021-01-21","kind":"tax_withholding","acquired":false,"shares":1427,"price":77.43,"value":110492.61,"ownership":{"direct":true},"balance_after":45076,"source":{"system":"sec-edgar","filing":"0001209191-21-005003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121005003/doc4.xml","form_type":"4"}},{"id":2899236,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-01-22T21:09:38.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":3220,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46503,"source":{"system":"sec-edgar","filing":"0001209191-21-005003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121005003/doc4.xml","form_type":"4"}},{"id":2915551,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":4354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":8708,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4354},"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2915550,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":10626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":10626,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10626},"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2915549,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":5634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2021-01-05","expiration_date":"2021-01-05","underlying":"Ordinary Shares","underlying_shares":5634},"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2915548,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":20957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":20957,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20957},"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2915547,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-05","kind":"tax_withholding","acquired":false,"shares":9230,"price":73.28,"value":676374.4,"ownership":{"direct":true},"balance_after":43283,"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2915546,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:12:09.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":20614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,070 ordinary shares of the Issuer acquired by the reporting person on December 1, 2020 pursuant to an employee stock purchase program."}],"balance_after":52513,"source":{"system":"sec-edgar","filing":"0001209191-21-002418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002418/doc4.xml","form_type":"4"}},{"id":2989693,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2020-11-06T18:00:21.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":3500,"price":76.7609,"value":268663.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $76.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30829,"source":{"system":"sec-edgar","filing":"0001209191-20-057343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120057343/doc4.xml","form_type":"4"}},{"id":3001482,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units","published_at":"2020-10-22T18:14:30.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in two annual installments of 10,000 shares on each anniversary of the grant date (October 1, 2018)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in two annual installments of 10,000 shares on each anniversary of the grant date (October 1, 2018)."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-055603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120055603/doc4.xml","form_type":"4"}},{"id":3001481,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2020-10-22T18:14:30.000Z","date":"2020-10-01","kind":"tax_withholding","acquired":false,"shares":4460,"price":80.42,"value":358673.2,"ownership":{"direct":true},"balance_after":34329,"source":{"system":"sec-edgar","filing":"0001209191-20-055603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120055603/doc4.xml","form_type":"4"}},{"id":3001480,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Ordinary Shares","published_at":"2020-10-22T18:14:30.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38789,"source":{"system":"sec-edgar","filing":"0001209191-20-055603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120055603/doc4.xml","form_type":"4"}},{"id":3067420,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":30934,"kind":"person","name":"Camardo Daniel A.","position":1,"cik":"0001820365","reported_name":"Camardo Daniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and President, U.S."}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-08-05T13:27:19.000Z","date":"2020-08-03","kind":"grant","acquired":false,"shares":17102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of August 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of August 1, 2020."}],"balance_after":17102,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17102},"source":{"system":"sec-edgar","filing":"0001209191-20-044994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120044994/doc4.xml","form_type":"4"}}]}